论文部分内容阅读
目的:探讨清肺化痰通腑汤辅助治疗痰热壅盛型肺癌的临床疗效。方法:收集2014年6月至2015年12月广西中医药大学附属瑞康医院呼吸内科、肿瘤科、放疗科收治的99例肺癌患者,采用随机分配法将其划分为治疗组(n=49例)与对照组(n=50例),两组均给予常规对症治疗,对照组在此基础上使用清金化痰汤治疗,治疗组在此基础上给予清肺化痰通腑汤进行治疗,观察两组患者临床治疗效果。结果:治疗前,两组C-反应蛋白含量比较,差异无统计学意义(P>0.05)。治疗组与对照组治疗总有效率分别为95.92%、78.00%,且治疗组治疗后C-反应蛋白水平明显低于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:痰热壅盛型肺癌患者给予清肺化痰通腑汤进行辅助治疗,能有效降低患者化疗放疗不良反应,改善患者肺部感染症状,进一步提高患者的生存质量。
Objective: To investigate the clinical curative effect of Qingfei Huatan Tongfu Decoction in the treatment of phlegm-heat type Sheng-lung cancer. Methods: A total of 99 lung cancer patients who were admitted to Department of Respiratory Medicine, Oncology and Radiotherapy, Ruikang Hospital, Guangxi University of Traditional Chinese Medicine from June 2014 to December 2015 were randomly divided into treatment group (n = 49) ) And control group (n = 50). Both groups were given conventional symptomatic treatment. On the basis of this, the control group was treated with Qingjinhuatan Decoction, and the treatment group was treated with Qingfei Huatan Tongfu Decoction on this basis. The clinical effects of two groups were observed. Results: Before treatment, there was no significant difference between the two groups in the content of C-reactive protein (P> 0.05). The total effective rates of the treatment group and the control group were 95.92% and 78.00%, respectively. The C-reactive protein level in the treatment group was significantly lower than that in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Patients with phlegm-heat type of lung cancer are given adjuvant therapy with Qingfei Huatan Tongfu Decoction, which can effectively reduce the adverse reactions of chemotherapy and radiotherapy in patients and improve the symptoms of pulmonary infection in patients, and further improve the quality of life of patients.